Het Algemeen Ziekenhuis Sint-Maarten is een katholiek ziekenhuis gelegen te Mechelen, behorend tot het zorgconglomeraat Emmaüs. Het AZ Sint-Maarten ontstond op 1 januari 1999 uit de fusie tussen het AZ Sint-Jozef te Mechelen en het AZ Sint-Norbertus te Duffel.

During the past decade, AZ Sint-Maarten conducted 35 clinical trials. In the 10-year time frame, 35 clinical trials started and 11 clinical trials were completed, i.e. on average, 31.4% percent of trials that started reached the finish line to date. In the past 5 years, 21 clinical trials started and 7 clinical trials were completed. i.e. 33.3% of trials that started reached the finish line.

Out of the total clinical trials conducted in "AZ Sint-Maarten" #1 sponsor was "Daiichi Sankyo, Inc." with 3 trials, followed by "Hoffmann-La Roche" with 3 trials sponsored, "Janssen Research & Development, LLC" with 3 trials sponsored, "Boehringer Ingelheim" with 2 trials sponsored and "Egetis Therapeutics" with 2 trials sponsored. Other sponsors include 26 different institutions and companies that sponsored additional 32 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "AZ Sint-Maarten" #1 collaborator was "Quintiles, Inc." with 2 trials as a collaborator, "Solasia Pharma K.K." with 2 trials as a collaborator, "3M" with 1 trials as a collaborator, "Agentschap voor Innovatie door Wetenschap en Technologie" with 1 trials as a collaborator and "AstraZeneca" with 1 trials as a collaborator. Other collaborators include 6 different institutions and companies that were collaborators in the rest 16 trials.

According to Clinical.Site data, the most researched conditions in "AZ Sint-Maarten" are "Chronic Obstructive Pulmonary Disease" (3 trials), "Colorectal Cancer" (3 trials), "Non-Small Cell Lung Cancer" (3 trials), "Small Cell Lung Cancer" (3 trials) and "Atrial Fibrillation" (2 trials). Many other conditions were trialed in "AZ Sint-Maarten" in a lesser frequency.

Most popular intervention types in "AZ Sint-Maarten" are "Drug" (34 trials), "Device" (5 trials), "Other" (4 trials), "Biological" (3 trials) and "Procedure" (2 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (14 trials), "Atezolizumab" (3 trials), "Carboplatin" (3 trials), "Cisplatin" (3 trials) and "Calmangafodipir (5 µmol/kg)" (2 trials). Other intervention names were less common.

The vast majority of trials in "AZ Sint-Maarten" are 40 trials for "All" genders and 4 trials for "Female" genders.

Currently, there are NaN active trials in "AZ Sint-Maarten". undefined are not yet recruiting, 13 are recruiting, 6 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 18 completed trials in AZ Sint-Maarten, 1 suspended trials, and 5 terminated clinical trials to date.

Out of the total trials that were conducted in AZ Sint-Maarten, 4 "Phase 1" clinical trials were conducted, 13 "Phase 2" clinical trials and 15 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 4 trials, and there were also 4 trials that are defined as “Not Applicable".